CHADIS Newsroom

Vlog: The Difference We Make in Healthcare | with Barbara Howard | The Top Floor

Pediatrics On Call: Barbara Howard, MD, FAAP, explains ways pediatricians can streamline the health-maintenance visit using technology.

Comparing substance use rates by self-administered screening versus clinician interview among youth in pediatric primary care.

Online Clinical Process Support as an Aid to Identification and Management of Developmental and Mental Health Problems

Trends in substance use screening results before and during the COVID-19 pandemic among youth in pediatric primary care

What Parents Want Doctors to Know: Responses to an Open-Ended Item on an Asthma Questionnaire

Parent report of Forward-Actionable Positive Childhood Experiences (FA-PCE) improves the clinical utility of the standard ACE

Identifying Children and Adolescents at Elevated Mental Health Risk Before and During COVID-19.

CHADIS is proud to announce the History of Present Illness form and having the resulting information create a visit note!

CHADIS featured in the Contemporary Pediatrics Best Tech issue.

Trends in substance use screening results before and during the COVID-19 pandemic among youth in pediatric primary care

Suicidal Ideation in Adolescents: Understanding Results from Screening with the PHQ-9M and the PSC-17P

Parent report of Forward-Actionable Positive Childhood Experiences (FA-PCE) improves the clinical utility of the standard ACE

Total Child Health, Inc., also known as CHADIS, has formally changed its name to CHADIS, Inc.

Developmental Milestone Attainment in US Children Before and During the COVID-19 Pandemic.

CHADIS Co-founder, Raymond Sturner, given Award for Pediatric Innovation at the 2022 AAP Conference

Phase II has been funded.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has awarded CHADIS a grant for the Validation of the Online Toddler Autism and Development Adaptive Screener (TADAS) at 18 months.

​

Do Autism-Specific and General Developmental Screens Have Complementary Clinical Value?

Autism screening at 18 months of age: a comparison of the Q-CHAT-10 and M-CHAT screeners. Molecular Autism

Parent report of Forward-Actionable Positive Childhood Experiences (FA-PCE) improves the clinical utility of the standard ACE